Valeant Pharmaceuticals (NYSE: VRX) Represents Everything Wrong with the Markets

Every once in a while, a single company combines virtually all of the market's most toxic forces. Today I feel it's my job to expose Valeant Pharmaceuticals International Inc. (NYSE: VRX). for such a company and for the bad investment it is. In fact, the firm was just subpoenaed by U.S. prosecutors, knocking shares down 9% in pre-market trading. Here's why. Tags: biopharma , NYSE: VRX , Valeant stock , Valeant stock price , VRX stock , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Valeant Pharmaceuticals (NYSE: VRX) Represents Everything Wrong with the Markets appeared first on Money Morning - We Make Investing Profitable .